Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

FY2027 EPS Estimate for Telix Pharmaceuticals Cut by Analyst

Summary by marketbeat.com
Telix Pharmaceuticals Limited (NASDAQ:TLX - Free Report) - Analysts at William Blair cut their FY2027 EPS estimates for Telix Pharmaceuticals in a note issued to investors on Thursday, August 21st. William Blair analyst A. Hsieh now anticipates that the company will post earnings per share of $0.49

1 Articles

marketbeat.commarketbeat.com
Center

FY2027 EPS Estimate for Telix Pharmaceuticals Cut by Analyst

Telix Pharmaceuticals Limited (NASDAQ:TLX - Free Report) - Analysts at William Blair cut their FY2027 EPS estimates for Telix Pharmaceuticals in a note issued to investors on Thursday, August 21st. William Blair analyst A. Hsieh now anticipates that the company will post earnings per share of $0.49

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news in on Tuesday, August 26, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Bill Blair icon

Bill Blair

Melbourne, Australia icon

Melbourne, Australia

News
For You
SearchBlindspotLocal